Aura Biosciences, Inc.
AURA
$5.36
-$0.04-0.74%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -86.92M | -83.22M | -80.69M | -78.65M | -76.41M |
| Total Depreciation and Amortization | 1.22M | 1.26M | 1.29M | 1.27M | 1.30M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.53M | 8.39M | 8.27M | 7.34M | 6.83M |
| Change in Net Operating Assets | -2.64M | 334.00K | -2.24M | -1.85M | 4.44M |
| Cash from Operations | -79.81M | -73.24M | -73.37M | -71.89M | -63.85M |
| Capital Expenditure | -1.25M | -1.27M | -1.02M | -688.00K | -709.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 70.07M | -49.72M | -38.23M | -37.00M | -113.25M |
| Cash from Investing | 68.82M | -50.99M | -39.25M | -37.69M | -113.96M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.60M | 94.04M | 94.95M | 97.34M | 97.29M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.60M | 94.04M | 94.95M | 97.34M | 97.29M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.39M | -30.20M | -17.68M | -12.23M | -80.52M |